Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
4.330
0.00 (0.00%)
At close: Feb 21, 2025, 4:00 PM
4.580
+0.250 (5.77%)
After-hours: Feb 21, 2025, 6:23 PM EST
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $46.70 million as of February 21, 2025. Its market cap has increased by 2.78% in one year.
Market Cap
46.70M
Enterprise Value
18.94M
1-Year Change
2.78%
Ranking
Category
Stock Price
$4.33
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $46.70M, an increase of 53.97%. That is a compound annual growth rate of 9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 46.70M | 35.74% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |